Noncoding RNA therapeutics—challenges and potential solutions
Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …
Targeted protein degradation: A promise for undruggable proteins
KTG Samarasinghe, CM Crews - Cell chemical biology, 2021 - cell.com
Summary Protein homeostasis, or" proteostasis," is indispensable for a balanced, healthy
environment within the cell. However, when natural proteostasis mechanisms are …
environment within the cell. However, when natural proteostasis mechanisms are …
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
SB Alabi, CM Crews - Journal of Biological Chemistry, 2021 - ASBMB
Of late, targeted protein degradation (TPD) has surfaced as a novel and innovative chemical
tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates …
tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates …
Reimagining druggability using chemoproteomic platforms
JN Spradlin, E Zhang, DK Nomura - Accounts of Chemical …, 2021 - ACS Publications
Conspectus One of the biggest bottlenecks in modern drug discovery efforts is in tackling the
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …
Reprogramming of protein-targeted small-molecule medicines to RNA by ribonuclease recruitment
Reprogramming known medicines for a novel target with activity and selectivity over the
canonical target is challenging. By studying the binding interactions between RNA folds and …
canonical target is challenging. By studying the binding interactions between RNA folds and …
Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells
SM Hücker, T Fehlmann, C Werno, K Weidele… - Nature …, 2021 - nature.com
Molecular single cell analyses provide insights into physiological and pathological
processes. Here, in a stepwise approach, we first evaluate 19 protocols for single cell small …
processes. Here, in a stepwise approach, we first evaluate 19 protocols for single cell small …
Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G4C2) repeat expansion in vitro and in vivo ALS models
JA Bush, H Aikawa, R Fuerst, Y Li, A Ursu… - Science translational …, 2021 - science.org
The most common cause of amyotrophic lateral sclerosis and frontotemporal dementia
(c9ALS/FTD) is an expanded G4C2 RNA repeat [r (G4C2) exp] in chromosome 9 open …
(c9ALS/FTD) is an expanded G4C2 RNA repeat [r (G4C2) exp] in chromosome 9 open …
A map of the SARS-CoV-2 RNA structurome
RJ Andrews, CA O'Leary, VS Tompkins… - NAR genomics and …, 2021 - academic.oup.com
SARS-CoV-2 has exploded throughout the human population. To facilitate efforts to gain
insights into SARS-CoV-2 biology and to target the virus therapeutically, it is essential to …
insights into SARS-CoV-2 biology and to target the virus therapeutically, it is essential to …
miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy
Simple Summary Cancer onset and progression are promoted by high deregulation of the
immune system. Recently, major advances in molecular and clinical cancer immunology …
immune system. Recently, major advances in molecular and clinical cancer immunology …
Inhibition of SARS-CoV-2 by targeting conserved viral RNA structures and sequences
The ongoing COVID-19/Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2)
pandemic has become a significant threat to public health and has hugely impacted …
pandemic has become a significant threat to public health and has hugely impacted …